Apigenin has moved from chamomile tea to supplement capsules faster than the science supporting it. The flavonoid’s reputation rests on a plausible mechanism—GABA-A receptor modulation, CDK inhibition, CD38 suppression—and a growing body of cell and animal studies. What’s far less clear is whether daily supplementation at doses above what food provides is safe over months or years.
This article reviews the available evidence honestly, including its limits. Most safety data comes from preclinical work or short-term dietary exposure, not controlled long-term human trials. If you’re considering apigenin as a daily supplement, understanding the gaps matters as much as knowing the potential benefits. This is informational only and does not constitute medical advice; these statements have not been evaluated by the FDA.
Key Takeaways
- Apigenin has a plausible mechanism and encouraging preclinical safety signals, but no long-term controlled human trials have confirmed safety at supplement doses.
- CYP1A2, CYP2C9, and CYP3A4 inhibition creates real drug interaction risk—anyone on warfarin, certain statins, or benzodiazepines needs physician review before adding apigenin.
- Weak phytoestrogenic activity is a theoretical concern for people with hormone-sensitive conditions or those on hormone therapies [9].
- Animal and cell studies consistently show anti-inflammatory and organ-protective effects [2] [12], but preclinical data does not directly establish safe human dosing ranges.
- Dietary apigenin from chamomile tea and food carries the longest safety record; concentrated supplements represent an evidence gap the research has not yet closed.
What Apigenin Is and How It Works
Apigenin (4′,5,7-trihydroxyflavone) is a plant-derived flavonoid found in chamomile flowers, parsley, celery, and several other common foods. At the molecular level it interacts with multiple biological targets: it binds benzodiazepine sites on GABA-A receptors, which helps explain the mild anxiolytic and sleep-onset effects attributed to chamomile; it inhibits cyclin-dependent kinases CDK2 and CDK6, which may slow the cell-cycle progression underlying its studied anti-cancer properties [5]; and it modestly inhibits CD38, an enzyme involved in NAD+ consumption.
Researchers have also described anti-inflammatory activity through multiple pathways. One study found that apigenin supplementation suppressed both canonical and non-canonical inflammasome signaling in a murine colitis model, reducing intestinal injury markers [2]. Separate animal work in carp showed protective effects on cardiac, renal, and intestinal tissue under chemical stress, modulated through oxidative-stress and inflammatory mechanisms [12]. These mechanistic findings are encouraging, but nearly all of them were generated in cell lines or animal models, which do not always translate to human physiology at equivalent doses.
Short-Term Safety: What Preclinical and Dietary Data Suggest
Apigenin consumed through food—chamomile tea, parsley, celery—has a long dietary history without widespread reports of harm, and regulators generally recognize flavonoids from these sources as safe at normal dietary intakes. Preclinical work also suggests a protective rather than toxic profile at moderate doses. In animal models, apigenin has been studied alongside other polyphenols as a potential guard against chemotherapy-related organ damage, with flavonoids broadly showing cytoprotective properties in these contexts [3].
Natural polyphenols including apigenin have been explored for radioprotective applications, and the existing preclinical literature characterizes their safety profile at studied doses as acceptable [7]. A review examining corn silk—a botanical source of apigenin and related flavonoids—included a safety evaluation noting that apigenin-rich extracts did not produce significant toxicity signals in the studies reviewed, though the authors emphasized the need for more rigorous clinical data before firm safety conclusions can be drawn [8].
Clinical safety data for flavonoid supplements in general—not apigenin specifically at high isolated doses—includes the Cochrane review on phlebotonics, a class of plant-derived flavonoid compounds used for venous insufficiency. That systematic review, drawing on multiple randomized controlled trials in humans, found the compounds were generally well tolerated over the study durations examined [4]. Apigenin is a distinct compound from the diosmin and hesperidin covered in that review, so this safety inference is indirect, but it adds context to the broader flavonoid safety picture.
Anti-Inflammatory Properties and Organ-Level Effects
A consistent theme across apigenin research is anti-inflammatory activity. Studies in rodent models have shown reduced inflammatory cytokine production and inhibition of inflammasome activation [2]. Tea-derived flavonoids, a chemical class that includes apigenin, have been reviewed for anti-inflammatory effects with documented reductions in inflammatory markers in controlled settings [1]. Whether these effects persist, diminish, or cause any compensatory downregulation of immune responses with long-term use remains unstudied in humans.
In a rabbit model involving a high-cholesterol diet, a combination including apigenin alongside betulinic acid and skimmianine modulated the CD36-TLR2 signaling pathway—a pathway involved in lipid uptake and inflammatory activation [6]. Animal studies like this one generate hypotheses about cardiovascular benefit; they do not establish safe dosing ranges for humans. The translation from an effective animal dose to a human-equivalent dose requires careful pharmacokinetic work that has not been fully completed for apigenin.
Long-Term Safety: The Honest Evidence Gap
The most important thing to say about apigenin’s long-term safety is that it has not been studied systematically in long-term human trials. Nearly all research uses cell lines or rodent models, and study durations rarely extend beyond a few weeks even in animals. This is not unique to apigenin—it reflects the early state of the broader flavonoid supplement field—but it matters considerably for anyone planning to take concentrated doses daily for months or years.
One area warranting particular attention is apigenin’s weak phytoestrogenic activity. Apigenin belongs to the broader family of plant compounds with estrogen-receptor affinity. Research on phytoestrogens in the context of bone health notes both potential protective effects on bone density and the theoretical possibility of hormonal interference at high doses in certain populations [9]. People with hormone-sensitive conditions—including estrogen-receptor-positive cancers, endometriosis, or those on hormone therapies—should weigh this uncertainty carefully before supplementing.
Cancer research on apigenin is a double-edged consideration for long-term safety assessment. Laboratory and animal studies show apigenin inhibiting cancer cell proliferation through CDK and apoptosis pathways [5], and novel nanoarchitectures are being explored to enhance delivery in drug-resistant colorectal cancer models [10]. However, compounds that interfere with CDK activity and promote apoptosis theoretically interact with the body’s normal cell-turnover processes in healthy tissue as well. The implications of sustained CDK inhibition over years in non-cancerous cells are not established. This does not mean harm is likely, but it does mean the long-term profile is genuinely unknown rather than simply unconfirmed as safe.
Drug Interactions: A Clinically Significant Concern
The most concrete long-term safety concern for supplement-dose apigenin is its inhibition of cytochrome P450 enzymes—specifically CYP1A2, CYP2C9, and CYP3A4. These enzymes metabolize a wide range of medications. CYP2C9 metabolizes warfarin; inhibiting it can raise warfarin blood levels and significantly increase bleeding risk. CYP3A4 metabolizes certain statins (simvastatin, lovastatin) and many other common drugs. CYP1A2 handles caffeine, theophylline, and some antidepressants.
Individuals taking warfarin, certain statins, benzodiazepines, or other CYP-substrate medications should consult a physician before adding apigenin supplements. This interaction risk scales with dose: dietary apigenin from chamomile tea poses a far lower interaction risk than a concentrated 50–200 mg supplement taken daily. Stacking apigenin with other sedatives—including melatonin or alcohol—also warrants caution given its GABA-A binding activity.
Research on polyphenolic compounds with neuroprotective properties suggests apigenin may modulate signaling pathways relevant to ischemic and vascular conditions [11], which further underlines the importance of medical review for anyone with cardiovascular conditions or taking related medications.
What Responsible Long-Term Use Would Look Like
Given the current evidence, a cautious approach to apigenin supplementation involves using the lowest dose that appears to serve your goal rather than escalating toward the upper end of what’s sold commercially. Many supplements provide 50 mg per serving; some go considerably higher. The dietary intake from a diet rich in chamomile, parsley, and celery—likely in the range of a few milligrams per day—has the longest safety record, even if it falls well below the doses used in preclinical studies.
Periodic review with a healthcare provider is reasonable for anyone supplementing long-term, especially those on prescription medications. There are no validated biomarkers that specifically track apigenin’s chronic effects in humans, so clinical monitoring would focus on known interaction risks—for example, INR monitoring if on warfarin, or liver enzyme checks if on concurrent statin therapy. The anti-inflammatory and organ-protective signals from preclinical work are promising [2] [12], but they should not be used to justify escalating doses in the absence of human safety data confirming tolerability at those levels.
🛒 Where to Buy Apigenin
- Momentous Momentous ApigeninLab-tested / studied
capsules, 50 mg per capsule — Andrew Huberman’s publicly recommended brand; NSF Certified for Sport; single-ingredient, no fillers - Double Wood Supplements Apigenin 50mg
capsules, 50 mg per capsule, 120 count — High-volume value pick; third-party tested for purity; frequently top-ranked on Amazon - Nutricost Apigenin 50mg
capsules, 50 mg per capsule, 120 count — FDA-registered facility; gluten-free, non-GMO; competitive price-per-dose - Swanson Apigenin 50mg
capsules, 50 mg per capsule, 90 count — Established supplement brand; GMP-certified manufacturing; widely available, low cost
As an Amazon Associate we earn from qualifying purchases. Shilajit quality varies widely — always choose a product with a published third-party heavy-metal test (COA) before buying.
A Note on the Evidence
Most apigenin safety evidence comes from animal and cell studies; no long-term human trials confirm safety at the doses found in commercially available supplements. Individuals on warfarin, CYP-metabolized statins, benzodiazepines, or with hormone-sensitive conditions should consult a physician before use. These statements have not been evaluated by the FDA; apigenin is not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
Has apigenin been tested in long-term human trials?
No long-term controlled human trials on apigenin supplementation have been published. Most evidence comes from cell culture studies and rodent models. The Cochrane review on flavonoid-class phlebotonics found acceptable tolerability in human trials, but those compounds differ meaningfully from isolated apigenin [4]. The honest answer is that the long-term human data simply does not exist yet.
Can apigenin interfere with my medications?
Yes, and this is a clinically meaningful concern rather than a theoretical one. Apigenin inhibits CYP1A2, CYP2C9, and CYP3A4—enzymes that metabolize warfarin, certain statins, benzodiazepines, and many other common drugs. Anyone on these medications should consult a physician before supplementing, particularly at doses above what dietary sources would provide.
Does apigenin affect hormone levels?
Apigenin has weak phytoestrogenic activity, meaning it can interact with estrogen receptors. Research on phytoestrogens in the context of bone health notes both potential protective effects on bone density and possible hormonal interference at higher intakes in certain populations [9]. People with hormone-sensitive conditions or those on hormone therapies should discuss this specifically with their healthcare provider.
Is chamomile tea a safer way to get apigenin than supplements?
For most people, yes. Chamomile tea contains apigenin at relatively low doses with a very long history of human use and no widespread adverse reports at typical consumption levels. Concentrated supplements deliver substantially higher amounts with far less safety history. If your goal is mild relaxation or modest anti-inflammatory support, dietary sources represent the more conservatively evidenced option.
What anti-inflammatory evidence exists for apigenin?
Animal studies have shown apigenin suppressing inflammasome signaling in intestinal tissue [2], and flavonoids in the same chemical class demonstrate anti-inflammatory effects across reviewed literature [1]. Separate animal work showed apigenin protecting cardiac and renal tissue against oxidative and inflammatory injury [12]. These are preclinical findings and have not been confirmed in long-term human studies at supplement doses.
Is apigenin being studied for cancer prevention or treatment?
Preclinical research shows apigenin inhibiting cell-cycle progression through CDK pathways and inducing apoptosis in cancer cell lines [5], and nanoformulations are being explored for drug-resistant colorectal cancer models [10]. This research is early-stage. Apigenin is not a proven cancer treatment, and these findings do not establish that long-term supplementation prevents cancer in healthy people or is safe for that purpose.
References
- Hoensch H et al. [Anti-inflammatory effects of tea-flavonoids]. Deutsche medizinische Wochenschrift (1946) (2012). PMID 23233307
- Márquez-Flores YK et al. Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways. The Journal of nutritional biochemistry (2016). PMID 27012631
- Navarro-Hortal MD et al. Role of flavonoids against adriamycin toxicity. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2020). PMID 33080329
- Martinez-Zapata MJ et al. Phlebotonics for venous insufficiency. The Cochrane database of systematic reviews (2020). PMID 33141449
- Ahmed SA et al. Rationalizing the therapeutic potential of apigenin against cancer. Life sciences (2021). PMID 33333052
- Sabu V et al. Synergistic effect of Betulinic acid, Apigenin and Skimmianine (BASk) in high cholesterol diet rabbit: Involvement of CD36-TLR2 signaling pathway. Cytokine (2021). PMID 33667961
- Adnan M et al. Radioprotective Role of Natural Polyphenols: From Sources to Mechanisms. Anti-cancer agents in medicinal chemistry (2022). PMID 33874875
- Gulati A et al. Anti-cancerous effect of corn silk: a critical review on its mechanism of action and safety evaluation. 3 Biotech (2023). PMID 37361240
- Kaczmarski M et al. Phytoestrogens in osteoporosis. Wiadomosci lekarskie (Warsaw, Poland : 1960) (2025). PMID 40219889
- Goleij P et al. Targeting drug resistant colorectal cancer with apigenin nanoarchitectures. Translational oncology (2025). PMID 40561797
- Zhang J et al. Polyphenolic metabolites in Scutellaria baicalensis as potential candidate agents for the treatment of ischemic stroke. Frontiers in pharmacology (2025). PMID 41322306
- Guan T et al. Apigenin alleviates DFZ-induced cardiac, renal, and intestinal injury in carp by modulating oxidative stress and inflammatory responses. Fish & shellfish immunology (2026). PMID 41349620
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
